Absorción de trazador óseo ávido ventricular derecho: un nuevo marcador de riesgo en la miocardiopatía amiloide

Sharmila Dorbala1

  • 1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Circulation
|April 8, 2024
PubMed
Resumen

No abstract available in PubMed .